Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Itraconazole

A broad-spectrum triazole antifungal, patented in 1978 and approved in the United States in 1992: it treats nail and skin fungal infections as well as deep infections such as aspergillosis and histoplasmosis. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.

Did you know?Laboratory studies found that it also blocks the Hedgehog signalling pathway and the growth of new blood vessels: this is why it is being studied as a possible anticancer drug.

ItraconazoleGo to the active ingredient →
ItraconazoleActive ingredientItraconazoleCat. No. P-I105-001CAS 84625-61-6

EDQM standards 2

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.